Olive Bottle 300ML Stainless Jar Dispenser Oil Cruet Kitchen Sauce Vinegar Steel Oil & Vinegar Dispensers


  1. Home
  2. Olive Bottle 300ML Stainless Jar Dispenser Oil Cruet Kitchen Sauce Vinegar Steel
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
300ML Bottle Olive Stainless Steel Vinegar Sauce Kitchen Cruet Oil Dispenser Jar
Condition: Open box: A new, unused item with absolutely no signs of wear. The item may be missing the original packaging, Material: Glass + Stainless Steel
MPN:

Does Not Apply

Brand:

Unbranded

Country/Region of Manufacture: China Color:

Silver










published on tue nov 09 2021

Olive Bottle 300ML Stainless Jar Dispenser Oil Cruet Kitchen Sauce Vinegar Steel Oil & Vinegar Dispensers

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

Olive Bottle 300ML Stainless Jar Dispenser Oil Cruet Kitchen Sauce Vinegar Steel Oil & Vinegar Dispensers

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS